Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol
OPEN Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 10 Feb 2016
LM Jacola, KR Krull, CH Pui, D Pei, C Cheng, WE Reddick and HM Conklin
Survivors of childhood acute lymphoblastic leukemia (ALL) treated with CNS-directed chemotherapy are at risk for neurocognitive deficits. Prospective longitudinal studies are needed to clarify the neurodevelopmental trajectory in this vulnerable population.
* Data courtesy of Altmetric.com